For research use only. Not for therapeutic Use.
Eltoprazine(CAT: I005726) is a selective serotonin 5-HT1A/1B receptor partial agonist widely used in neuropharmacological research. It is particularly valuable for studying serotonergic signaling and its effects on behavioral and cognitive functions, including aggression, impulsivity, and mood regulation. Eltoprazine is also being explored for its therapeutic potential in treating neurological conditions such as Parkinson’s disease-related dyskinesia, attention-deficit/hyperactivity disorder (ADHD), and schizophrenia. With high specificity and stability, it is suitable for in vitro and in vivo studies, providing researchers with a reliable tool for investigating serotonergic pathways and developing targeted therapies for neuropsychiatric disorders.
| Catalog Number | I005726 |
| CAS Number | 98224-03-4 |
| Synonyms | DU28853 |
| Molecular Formula | C12H16N2O2 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine |
| InChI | InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2 |
| InChIKey | WVLHGCRWEHCIOT-UHFFFAOYSA-N |
| SMILES | C1CN(CCN1)C2=C3C(=CC=C2)OCCO3 |
